Companies

Yarrow Bioscience, Inc. (YARW) SEC filings

CIK 0001566044 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2024FY2023FY2022FY2021
Revenue (USD)42400047700093100021.0 M
Net income (USD)-28.5 M-23.2 M-73.3 M-255.6 M
Diluted EPS (USD/shares)-2.78-7.28-25.647.88

Latest filings

FiledFormDescriptionPeriod
2026-10-07SCHEDULE 13GSCHEDULE 13G
2026-09-17SCHEDULE 13GSCHEDULE 13G
2026-09-148-KFORM 8-K items 1.01,9.012026-09-10
2026-09-11424B5424B5
2026-09-11424B5424B5
2026-09-108-KFORM 8-K items 8.01,9.012026-09-10
2026-08-19EFFECTEFFECT items ,,
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-14POS AMPOS AM
2026-08-138-K/AFORM 8-K/A items 2.02,7.01,9.012026-07-24
2026-08-1310-Q10-Q2026-06-30
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-08-05SCHEDULE 13DSCHEDULE 13D
2026-08-04SCHEDULE 13GSCHEDULE 13G
2026-08-03SCHEDULE 13GSCHEDULE 13G
2026-07-30SCHEDULE 13GSCHEDULE 13G
2026-07-304OWNERSHIP DOCUMENT2026-07-29
2026-07-308-KFORM 8-K items 8.012026-07-29
2026-07-303OWNERSHIP DOCUMENT2026-07-27
2026-07-294OWNERSHIP DOCUMENT2026-07-27
2026-07-294OWNERSHIP DOCUMENT2026-07-27
2026-07-293OWNERSHIP DOCUMENT2026-07-27

Forms on file (last 1,000): 4 268, 8-K 130, 3 45, 10-Q 26, SC 13G/A 20, 425 18, CORRESP 16, SC 13G 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=YARW (0.002 USD), /gw/filings/filings?ticker=YARW&form=8-K, /gw/filings/facts?ticker=YARW&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange